Quantcast
Last updated on April 17, 2014 at 14:51 EDT

Latest Medical statistics Stories

2014-02-18 23:25:00

Collaboration will create methodologies to drive improved decision-making in exploratory phase development. Reston, Virginia (PRWEB) February 18, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the adoption of innovative clinical trial approaches such as adaptive design, today announced that Novartis Pharma AG, Janssen Pharmaceuticals Inc, and Eli Lilly have joined them in co-founding the ADDPLAN DF Consortium. The members of the...

2014-02-12 04:21:06

MINNEAPOLIS, Feb. 12, 2014 /PRNewswire-USNewswire/ -- DaVita Clinical Research(®) (DCR(®)), a specialty contract research organization with services spanning the full spectrum of drug and device development, announced today that it has entered into an agreement through which Pyxant Labs Inc. will provide bioanalytical laboratory services for DCR's early clinical trials. (Logo: http://photos.prnewswire.com/prnh/20140212/DC63568LOGO) "Pyxant's proven track record and overall...

2014-02-04 12:27:27

ALMERE, The Netherlands, February 4, 2014 /PRNewswire/ -- On January 29th, 2014, Emotional Brain received the Scientific Advice letters from the European Medicines Agency (EMA) for the products Lybrido and Lybridos. The company is very pleased to announce that virtually all company proposals on the development plans for the two products were endorsed. Emotional Brain has adopted a personalized approach to medicine in the development of two drugs for the treatment of...

2014-02-03 12:29:34

RESEARCH TRIANGLE PARK, N.C., Feb. 3, 2014 /PRNewswire/ -- Dr. Renu Razdan, Vice President ACRO India and also the Chief Operating Officer, Max Neeman Medical International welcomes the new timelines and guidelines set up by the Drug Controller General of India [DCGI] for approval of clinical trials. The Drug regulatory authority in India has provided written confirmation to the pharmaceutical industry and Investigators that, clinical trial approval will be given within 180 days of...

2014-01-31 23:03:19

SureTrial® eTMF’s rapid cloud deployment, ease-of-use, and unique medical imaging support for clinical trials is helping leading dermatology products companies win FDA clearance. The successful deployment and FDA approval by users of SureTrial eTMF cloud is further proof that BioPharma companies are increasingly automating manual paper-based clinical trial approaches with SureClinical’s SureTrial eTMF cloud application. Rancho Cordova, CA (PRWEB) January 31, 2014 SureClinical,...

2014-01-31 12:25:34

DUBLIN, January 31, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/nl7858/medical_device) has announced the addition of the "Medical Device: Clinical Development Market Assessment" [http://www.researchandmarkets.com/research/nl7858/medical_device ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The report provides the medical device industry and its service providers with a new...

2014-01-27 08:27:50

Latest Data from Large Subgroup of Patients Shows that the Combination of ThermoDox® and Optimized RFA Provides a Statistically Significant Survival Improvement of Over 50% LAWRENCEVILLE, N.J., Jan. 27, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced that the latest overall survival data from its post-hoc analysis of results from the Company's Phase III HEAT Study of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin in...

2014-01-23 08:31:39

Partnership with ViS Research Has the Potential to Cut in Half the Time Needed to Conduct Clinical Trial Feasibility Studies Through Process Innovation BURLINGTON, Mass., Jan. 23, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment Solutions (iCTRS), an inVentiv Health company leading the biopharmaceutical sector in reducing the time to the start of clinical trials, announced today that the process innovations offered by its partnership with ViS could cut in half the time...

2014-01-16 10:04:50

1 in 40 people now affected; highest rates in Wales and North East of England UK rates of gout have soared since the late1990s, with one in every 40 people now affected by the condition - the highest in Europe - but treatment remains as poor now as it was then, reveals research published online in the Annals of the Rheumatic Diseases. But there is wide variation in both the prevalence (existing cases) and incidence (new cases) of gout across the UK, with the highest numbers of cases in...

2013-12-06 23:19:40

Xtalks presents a new and informative quality management webinar examining quality principles that help deliver superlative clinical research. The webinar takes place on December 18th, 2013 at 1:00 pm EST. Toronto, Canada (PRWEB) December 06, 2013 A sound Quality Management System is the underpinning of true human subject protection in clinical research. Research ethics committees are charged with protecting the rights and welfare of research participants and, along with regulatory...